We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.7M
AUM Growth
+$15.6M
Cap. Flow
+$11.7M
Cap. Flow %
14.33%
Top 10 Hldgs %
57.21%
Holding
75
New
23
Increased
16
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.33M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$933K
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$879K
4
CMG icon
Chipotle Mexican Grill
CMG
+$876K
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$719K

Top Sells

Rank Stock Value
1
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$888K
2
PRGO icon
Perrigo
PRGO
+$529K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$387K
4
GREK
Global X MSCI Greece ETF
GREK
+$365K
5
SGEN
Seagen Inc. Common Stock
SGEN
+$354K

Sector Composition

Rank Sector Weight
1 Healthcare 24.22%
2 Consumer Discretionary 11.94%
3 Financials 11.46%
4 Communication Services 8%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PXD
51
DELISTED
Pioneer Natural Resource Co.
PXD
$354K 0.43%
+2,400
New +$345K
PE
52
DELISTED
PARSLEY ENERGY INC
PE
$350K 0.43%
+13,300
New +$351K
GDXJ icon
53
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$336K 0.41%
10,000
– –
EIGI
54
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$310K 0.38%
37,847
– –
UA icon
55
Under Armour Class C
UA
$2.53B
$300K 0.37%
20,000
– –
DHC
56
Diversified Healthcare Trust
DHC
$2.14B
$291K 0.36%
14,877
– –
BIVV
57
DELISTED
Bioverativ Inc. Common Stock
BIVV
$266K 0.33%
+4,663
New +$273K
SRPT icon
58
Sarepta Therapeutics
SRPT
$1.77B
$265K 0.32%
+5,832
New +$233K
NBIS
59
Nebius Group N.V.
NBIS
$47.7B
$221K 0.27%
+6,693
New +$204K
VWTR
60
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$220K 0.27%
13,196
– –
BTU icon
61
Peabody Energy
BTU
$2.9B
$214K 0.26%
+7,368
New +$208K
PCRX icon
62
Pacira BioSciences
PCRX
$997M
$197K 0.24%
+5,247
New +$211K
ARRY
63
DELISTED
Array Biopharma Inc
ARRY
$144K 0.18%
+11,686
New +$109K
GREK
64
Global X MSCI Greece ETF
GREK
$316M
$136K 0.17%
4,800
-11,867
-71% -$365K
GTE icon
65
Gran Tierra Energy
GTE
$317M
$105K 0.13%
4,594
– –
SAN icon
66
Banco Santander
SAN
$210B
$104K 0.13%
15,652
– –
CLF icon
67
Cleveland-Cliffs
CLF
$6.99B
$87K 0.11%
12,114
– –
EQS icon
68
Equus Total Return
EQS
$16.8M
$46K 0.06%
19,073
– –
MTL.PR
69
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$42K 0.05%
44,298
– –
GMO
70
DELISTED
General Moly, Inc.
GMO
$8K 0.01%
20,895
– –
BMRN icon
71
BioMarin Pharmaceuticals
BMRN
$12.4B
– –
-3,424
Closed -$311K
EWZ icon
72
iShares MSCI Brazil ETF
EWZ
$8.95B
– –
-26,000
Closed -$888K
PRGO icon
73
Perrigo
PRGO
$1.78B
– –
-7,000
Closed -$529K
SGEN
74
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-6,848
Closed -$354K
UCP
75
DELISTED
UCP, Inc.
UCP
– –
-31,291
Closed -$343K
1 2
3

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Kazazian Asset Management held 75 positions worth $81.7M, up 24% from $66.1M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Kazazian Asset Management deployed $11.7M of net new capital in Q3 2017, opening 23 new positions and adding to 16 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 8,666 shares worth $503K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $387K trimmed.

  • Kazazian Asset Management's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 8,666 shares worth $503K.
  • Kazazian Asset Management added most to Biogen in Q3 2017, an estimated $1.33M increase.
  • Kazazian Asset Management's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $387K.
  • Kazazian Asset Management fully exited iShares MSCI Brazil ETF in Q3 2017, selling an estimated $888K.
  • Kazazian Asset Management's ten largest holdings make up 57% of its $81.7M portfolio in Q3 2017.
  • Kazazian Asset Management opened 23 new positions and closed 5 in Q3 2017.
  • Kazazian Asset Management's portfolio value rose 24% quarter-over-quarter to $81.7M.

Based on Kazazian Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.